Pacific Biosciences Company Insiders

PACB Stock  USD 1.85  0.05  2.78%   
Pacific Biosciences employs about 796 people. The company is managed by 12 executives with a total tenure of roughly 1858 years, averaging almost 154.0 years of service per executive, having 66.33 employees per reported executive. Analysis of Pacific Biosciences' management performance can provide insight into the company performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Pacific Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.1061) % which means that it has lost $0.1061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.648) %, meaning that it created substantial loss on money invested by shareholders. Pacific Biosciences' management efficiency ratios could be used to measure how well Pacific Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Pacific Biosciences Workforce Comparison

Pacific Biosciences of is regarded second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,913. Pacific Biosciences totals roughly 796 in number of employees claiming about 27% of equities under Health Care industry.
The company has Profit Margin (PM) of (2.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.4.

Pacific Biosciences Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pacific Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pacific Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Pacific Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Pacific Biosciences Notable Stakeholders

A Pacific Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pacific Biosciences often face trade-offs trying to please all of them. Pacific Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pacific Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Christian MBACEO PresidentProfile
Brett JDGeneral SecretaryProfile
Stephen TurnerCoFounder CTOProfile
Susan KimChief OfficerProfile
Jeff EidelChief OfficerProfile
Denis ZaccarinSenior DevelopmentProfile
Michele CPAVP OfficerProfile
Jonas KorlachChief OfficerProfile
Mike GoloubefSenior QualityProfile
Trevin RardHead RelationsProfile
Mark OeneChief OfficerProfile
Natalie WelchChief OfficerProfile

About Pacific Biosciences Management Performance

The success or failure of an entity such as Pacific Biosciences often depends on how effective the management is. Pacific Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pacific management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pacific management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California. Pacific Biosciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 728 people.
Please note, the presentation of Pacific Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pacific Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pacific Biosciences' management manipulating its earnings.

Pacific Biosciences Workforce Analysis

Traditionally, organizations such as Pacific Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pacific Biosciences within its industry.

Pacific Biosciences Manpower Efficiency

Return on Pacific Biosciences Manpower

Revenue Per Employee251.9K
Revenue Per Executive16.7M
Net Loss Per Employee385.3K
Net Loss Per Executive25.6M
Working Capital Per Employee812.8K
Working Capital Per Executive53.9M

Complementary Tools for Pacific Stock analysis

When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges